companies developing glp 1 drugs GLP-1 Revolution Transforms Obesity Treatment | Siddhi Patil posted on the topic It Is a Huge Market.

Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. Where some medtech leaders might see GLP-1 drugs as a big threat to their territory, Farrell sees it as an opportunity to funnel more people toward CPAP treatment by boosting awareness of chronic diseases like sleep apnea, and driving more people who suffer from these diseases into treatment pathways they may not have been previously open to or aware of, such as CPAP machines

Multi-specific peptides have emerged as promising therapeutic strategies for clinical weight loss

#Lotessa #GLP-1 #ObesityCare #DiabetesCare #UKHealthcare #Weightmanagement #NHS #Mounjaro #Wegovy #tirzepatide #pharma Bradford-Renduchintala Enterprise Ecosystem To view or add a comment, sign in Postpartum haemorrhage (PPH) is one of the leading causes for maternal deaths

Preclinical and clinical data suggest that FXR and PPAR dual modulators can improve insulin sensitivity, reduce hepatic steatosis, and attenuate fibrosis, which may complement the actions of GLP-1/GIP/GCG receptors agonists

It just depends on the labs, the results, what's going on with your health